| The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. | |
| | |
MedLine Citation:
|
PMID: 17223872 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: While many studies have demonstrated the efficacy and safety of tacrolimus ointment in the treatment of atopic dermatitis (AD), only a few have investigated the effects of tacrolimus on inflammatory cells and their cytokine gene expression in patients with AD. OBJECTIVES: To characterize further the immunophenotype of infiltrating cells and the production of certain cytokines before and after treatment with topical tacrolimus and hydrocortisone butyrate. METHODS: Nine adult patients with moderate to severe AD were treated with tacrolimus ointment, while seven control patients were treated with hydrocortisone butyrate ointment. We performed lesional skin biopsies before and after treatment. These were stained immunohistochemically with a panel of monoclonal antibodies including those to CD1a, CD3, CD4, CD8, myeloperoxidase, EG1, EG2, tryptase, interferon-gamma, interleukin (IL)-4, IL-5, IL-12, IL-13, receptors for CXC chemokines (CXCR) 3 and 4, and receptor 3 for CC chemokines. RESULTS: CD3+, CD4+ and CD8+ lymphocytes, and eosinophil and neutrophil granulocytes were significantly reduced in post-treatment tacrolimus specimens, while CD1a+ cells and mast cells were not. The expression of cytokines and chemokine receptors tested, except for CXCR3, was diminished by tacrolimus treatment. Moreover, tacrolimus produced a greater reduction of lymphocytes, eosinophils and most cytokines than that induced by hydrocortisone butyrate. CONCLUSIONS: Tacrolimus not only inhibits T-lymphocyte proliferation and cytokine production, but also plays an important role in the IL-12-induced shift from a T-helper (Th) 2 to a Th1 cytokine profile that characterizes the development of chronic AD. Tacrolimus also demonstrates wider pharmacodynamic effects than hydrocortisone. |
| | |
Authors:
|
M Caproni; D Torchia; E Antiga; M Terranova; W Volpi; E del Bianco; A D'Agata; P Fabbri |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: The British journal of dermatology Volume: 156 ISSN: 0007-0963 ISO Abbreviation: Br. J. Dermatol. Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-01-16 Completed Date: 2007-06-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0004041 Medline TA: Br J Dermatol Country: England |
Other Details:
|
Languages: eng Pagination: 312-9 Citation Subset: IM |
Affiliation:
|
Department of Dermatological Sciences, University of Florence, Via della Pergola 58/60, 50121 Florence, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Adult Aged Antibodies, Monoclonal / diagnostic use Cytokines / metabolism* Dermatitis, Atopic / drug therapy*, metabolism Female Humans Hydrocortisone / therapeutic use* Immunohistochemistry Immunosuppressive Agents / therapeutic use* Male Middle Aged Ointments Receptors, Cytokine / metabolism Tacrolimus / therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Cytokines; 0/Immunosuppressive Agents; 0/Ointments; 0/Receptors, Cytokine; 109581-93-3/Tacrolimus; 50-23-7/Hydrocortisone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of actinomycetoma due to Nocardia spp. with amoxicillin-clavulanate.
Next Document: Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study ...